Plain-English translation of NCT07035587 on ClinicalTrials.gov ↗ ·
Researchers are developing a highly sensitive blood test that can detect tiny amounts of cancer DNA in your bloodstream. This test could help doctors find cancer earlier and track whether treatment is working by measuring cancer-related DNA changes in blood samples over time.
Current methods of detecting cancer and monitoring treatment response often come too late or require invasive procedures. This new blood test aims to catch cancer at earlier, more treatable stages and give doctors a simpler, non-invasive way to watch for cancer recurrence after treatment.
You likely qualify if…
You likely don't qualify if…
If you have cancer, you will give blood samples multiple times: before treatment starts, after surgery or chemotherapy, and during follow-up visits over time. If you are a healthy control, you will give one blood sample. All samples will be tested for cancer-related DNA and other markers. Researchers may also compare mutations found in your blood with mutations from a tissue sample taken during surgery.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
South Korea